{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:05:47Z","timestamp":1794319547797,"version":"4.9.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"38","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ESC EORP. Funding from \u2018Zabawas Foundation\u2019 and \u2018De Hoop Foundation\u2019"},{"name":"Abbott Vascular Int"},{"name":"Amgen Cardiovascular"},{"name":"AstraZeneca"},{"DOI":"10.13039\/100004326","name":"Bayer AG (","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Boehringer Ingelheim"},{"name":"Boston Scientific"},{"name":"The Bristol Myers Squibb and Pfizer Alliance"},{"DOI":"10.13039\/501100022274","name":"Daiichi Sankyo Europe GmbH","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022274","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company"},{"DOI":"10.13039\/100006520","name":"Edwards","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Gedeon Richter Plc"},{"name":"Menarini Int. Op."},{"name":"MSD-Merck & Co"},{"name":"Novartis Pharma AG"},{"DOI":"10.13039\/100017647","name":"ResMed","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017647","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sanofi"},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Vifor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Hypertensive disorders of pregnancy (HDP) occur in 10% of pregnancies in the general population, pre-eclampsia specifically in 3\u20135%. Hypertensive disorders of pregnancy may have a high prevalence in, and be poorly tolerated by, women with heart disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and\u00a0results<\/jats:title>\n                  <jats:p>The prevalence and outcomes of HDP (chronic hypertension, gestational hypertension or pre-eclampsia) were assessed in the ESC EORP ROPAC (n\u2009=\u20095739), a worldwide prospective registry of pregnancies in women with heart disease.<\/jats:p>\n                  <jats:p>The overall prevalence of HDP was 10.3%, made up of chronic hypertension (5.9%), gestational hypertension (1.3%), and pre-eclampsia (3%), with significant differences between the types of underlying heart disease (P\u2009&amp;lt;\u20090.05). Pre-eclampsia rates were highest in women with pulmonary arterial hypertension (PAH) (11.1%), cardiomyopathy (CMP) (7.1%), and ischaemic heart disease (IHD) (6.3%). Maternal mortality was 1.4 and 0.6% in women with vs. without HDP (P\u2009=\u20090.04), and even 3.5% in those with pre-eclampsia. All pre-eclampsia-related deaths were post-partum and 50% were due to heart failure. Heart failure occurred in 18.5 vs. 10.6% of women with vs. without HDP (P\u2009&amp;lt;\u20090.001) and in 29.1% of those with pre-eclampsia. Perinatal mortality was 3.1 vs. 1.7% in women with vs. without HDP (P\u2009=\u20090.019) and 4.7% in those with pre-eclampsia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Hypertensive disorders of pregnancy and pre-eclampsia rates were higher in women with CMP, IHD, and PAH than in the general population. Adverse outcomes were increased in women with HDP, and maternal mortality was strikingly high in women with pre-eclampsia. The combination of HDP and heart disease should prompt close surveillance in a multidisciplinary context and the diagnosis of pre-eclampsia requires hospital admission and continued monitoring during the post-partum period.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehac308","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T17:07:20Z","timestamp":1655831240000},"page":"3749-3761","source":"Crossref","is-referenced-by-count":39,"title":["Hypertensive disorders of pregnant women with heart disease: the ESC EORP ROPAC Registry"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6741-2603","authenticated-orcid":false,"given":"Karishma P","family":"Ramlakhan","sequence":"first","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam , Rg-435 - P.O. Box: 2040, Rotterdam, 3000 CA , The Netherlands"},{"name":"Department of Obstetrics and Fetal Medicine, Erasmus MC\u2014Sophia\u2019s Children\u2019s Hospital, University Medical Center Rotterdam , Rotterdam, 3000 CB , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9140-8735","authenticated-orcid":false,"given":"Isabelle","family":"Malham\u00e9","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University Health Centre , Montreal, QC H4A 3J1 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1784-8206","authenticated-orcid":false,"given":"Ariane","family":"Marelli","sequence":"additional","affiliation":[{"name":"McGill Adult Unit for Congenital Heart Disease (MAUDE Unit), Department of Medicine, McGill University Health Centre , Montreal, QC H4A 3J1 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5899-291X","authenticated-orcid":false,"given":"Tobias","family":"Rutz","sequence":"additional","affiliation":[{"name":"Service of Cardiology, Lausanne University Hospital and University of Lausanne , Lausanne, CH-1011 , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5821-1113","authenticated-orcid":false,"given":"Sorel","family":"Goland","sequence":"additional","affiliation":[{"name":"Heart Institute, Kaplan Medical Center, Rehovot, Hebrew University and Hadassah Medical School , Rehovot, 76100 and Jerusalem, 9112102 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8801-5546","authenticated-orcid":false,"given":"Arie","family":"Franx","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Fetal Medicine, Erasmus MC\u2014Sophia\u2019s Children\u2019s Hospital, University Medical Center Rotterdam , Rotterdam, 3000 CB , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8272-0911","authenticated-orcid":false,"given":"Karen","family":"Sliwa","sequence":"additional","affiliation":[{"name":"Cape Heart Institute, Department of Medicine and Cardiology, University of Cape Town , Cape Town, 7925 , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3150-5709","authenticated-orcid":false,"given":"Uri","family":"Elkayam","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiovascular Medicine and Department of Obstetrics and Gynecology, University of Southern California, Keck School of Medicine , Los Angeles, CA 90033 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1096-9918","authenticated-orcid":false,"given":"Mark R","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Obstetric Medicine, Imperial College London, Chelsea and Westminster Hospital , London SW7 2BX , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Norwich Medical School, University of East Anglia , Norwich NR4 7TJ , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Cornette","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Fetal Medicine, Erasmus MC\u2014Sophia\u2019s Children\u2019s Hospital, University Medical Center Rotterdam , Rotterdam, 3000 CB , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6770-3830","authenticated-orcid":false,"given":"Jolien W","family":"Roos-Hesselink","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam , Rg-435 - P.O. Box: 2040, Rotterdam, 3000 CA , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"key":"2023011417263265700_ehac308-B1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","article-title":"Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy","volume":"25","author":"Hutcheon","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2023011417263265700_ehac308-B2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"key":"2023011417263265700_ehac308-B3","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1093\/eurheartj\/ehz136","article-title":"Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC)","volume":"40","author":"Roos-Hesselink","year":"2019","journal-title":"Eur Heart J"},{"key":"2023011417263265700_ehac308-B4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/HYPERTENSIONAHA.118.11191","article-title":"Cardiovascular system in preeclampsia and beyond","volume":"73","author":"Thilaganathan","year":"2019","journal-title":"Hypertension"},{"key":"2023011417263265700_ehac308-B5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/GCO.0000000000000419","article-title":"Cardiovascular origins of preeclampsia","volume":"29","author":"Kalafat","year":"2017","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2023011417263265700_ehac308-B6","doi-asserted-by":"crossref","first-page":"987.e15","DOI":"10.1016\/j.cjca.2015.12.011","article-title":"Secular trends in preeclampsia incidence and outcomes in a large Canada database: a longitudinal study over 24 years","volume":"32","author":"Auger","year":"2016","journal-title":"Can J Cardiol"},{"key":"2023011417263265700_ehac308-B7","first-page":"e1","article-title":"ACOG practice bulletin No. 202: gestational hypertension and preeclampsia","volume":"133","author":"The American College of Obstetricians and Gynecologists","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2023011417263265700_ehac308-B8","first-page":"1","volume-title":"Saving Lives, Improving Mothers\u2019 Care\u2014Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2015-17","author":"Knight","year":"2019"},{"key":"2023011417263265700_ehac308-B9","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0140-6736(19)31963-4","article-title":"Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial","volume":"394","author":"Chappell","year":"2019","journal-title":"Lancet"},{"key":"2023011417263265700_ehac308-B10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cardfail.2016.12.011","article-title":"Heart failure in late pregnancy and postpartum: incidence and long-term mortality in sweden from 1997 to 2010","volume":"23","author":"Barasa","year":"2017","journal-title":"J Card Fail"},{"key":"2023011417263265700_ehac308-B11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/heartjnl-2013-304888","article-title":"Heart failure in pregnant women with cardiac disease: data from the ROPAC","volume":"100","author":"Ruys","year":"2014","journal-title":"Heart"},{"key":"2023011417263265700_ehac308-B12","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.amjcard.2017.02.003","article-title":"National trends and in-hospital outcomes in pregnant women with heart disease in the United States","volume":"119","author":"Lima","year":"2017","journal-title":"Am J Cardiol"},{"key":"2023011417263265700_ehac308-B13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1001\/jamacardio.2017.0283","article-title":"Maternal and fetal outcomes of admission for delivery in women with congenital heart disease","volume":"2","author":"Hayward","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2023011417263265700_ehac308-B14","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.jacc.2007.03.027","article-title":"Outcome of pregnancy in women with congenital heart disease: a literature review","volume":"49","author":"Drenthen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2023011417263265700_ehac308-B15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/uog.20148","article-title":"Maternal right ventricular function, uteroplacental circulation in first trimester and pregnancy outcome in women with congenital heart disease","volume":"54","author":"Siegmund","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2023011417263265700_ehac308-B16","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1161\/CIRCULATIONAHA.113.002810","article-title":"Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease","volume":"128","author":"Pieper","year":"2013","journal-title":"Circulation"},{"key":"2023011417263265700_ehac308-B17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehs270","article-title":"Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology","volume":"34","author":"Roos-Hesselink","year":"2013","journal-title":"Eur Heart J"},{"key":"2023011417263265700_ehac308-B18","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"2023011417263265700_ehac308-B19","author":"United Nations DoEaSA, Statistics Division"},{"key":"2023011417263265700_ehac308-B20","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2023011417263265700_ehac308-B21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/uog.22174","article-title":"Incidence of pre-eclampsia and other perinatal complications among pregnant women with congenital heart disease: systematic review and meta-analysis","volume":"58","author":"Martinez-Portilla","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2023011417263265700_ehac308-B22","doi-asserted-by":"crossref","first-page":"544.e1","DOI":"10.1016\/j.ajog.2013.08.019","article-title":"Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease","volume":"209","author":"Lisonkova","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"2023011417263265700_ehac308-B23","doi-asserted-by":"crossref","first-page":"S1006","DOI":"10.1016\/j.ajog.2020.10.052","article-title":"Preeclampsia has two phenotypes which require different treatment strategies","volume":"226","author":"Masini","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"2023011417263265700_ehac308-B24","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ Res"},{"key":"2023011417263265700_ehac308-B25","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1253\/circj.CJ-16-1193","article-title":"Imbalanced angiogenesis in peripartum cardiomyopathy- diagnostic value of placenta growth factor","volume":"81","author":"Mebazaa","year":"2017","journal-title":"Circ J"},{"key":"2023011417263265700_ehac308-B26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbrc.2015.07.143","article-title":"Autoantibodies in dilated cardiomyopathy induce vascular endothelial growth factor expression in cardiomyocytes","volume":"465","author":"Saygili","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"2023011417263265700_ehac308-B27","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1161\/CIRCULATIONAHA.117.031527","article-title":"Cardiomyopathy and preeclampsia","volume":"138","author":"Gammill","year":"2018","journal-title":"Circulation"},{"key":"2023011417263265700_ehac308-B28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.vph.2015.03.005","article-title":"The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)","volume":"71","author":"Siti","year":"2015","journal-title":"Vascul Pharmacol"},{"key":"2023011417263265700_ehac308-B29","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial","volume":"359","author":"Altman","year":"2002","journal-title":"Lancet"},{"key":"2023011417263265700_ehac308-B30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/aogs.12533","article-title":"Reducing maternal mortality from preeclampsia and eclampsia in low-resource countries\u2013what should work?","volume":"94","author":"Goldenberg","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2023011417263265700_ehac308-B31","first-page":"533","article-title":"Pregnancy-related mortality from preeclampsia and eclampsia","volume":"97","author":"MacKay","year":"2001","journal-title":"Obstet Gynecol"},{"key":"2023011417263265700_ehac308-B32","doi-asserted-by":"crossref","first-page":"582.e1","DOI":"10.1016\/j.ajog.2019.02.010","article-title":"Severe cardiovascular morbidity in women with hypertensive diseases during delivery hospitalization","volume":"220","author":"Ackerman","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"2023011417263265700_ehac308-B33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"2023011417263265700_ehac308-B34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/uog.18987","article-title":"Pre-eclampsia and heart failure: a close relationship","volume":"52","author":"Orabona","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2023011417263265700_ehac308-B35","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2021.09.1360","article-title":"Preeclampsia predicts risk of hospitalization for heart failure with preserved ejection fraction","volume":"78","author":"Dominique","year":"2021","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/38\/3749\/48713922\/ehac308.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/38\/3749\/48713922\/ehac308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T17:27:38Z","timestamp":1673717258000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/38\/3749\/6612238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":35,"journal-issue":{"issue":"38","published-online":{"date-parts":[[2022,6,21]]},"published-print":{"date-parts":[[2022,10,11]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehac308","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,7]]},"published":{"date-parts":[[2022,6,21]]}}}